Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease

Table 1

Primer list.

Target	Sequence	Length
GAPDH	5’ AGTGCCAGCCTCGTCTCATA 3′	252 bp
	3’ GACTGTGCCGTTGAACTTGC 5′
SREBP	5’ GTTAACGTGGGTCTCCTCCG 3′	168 bp
	3’ CCAGCATAGGGGGCATCAAA 5′
Leptin	5’ GGTGGCTGGTTTGTTTCTGT 3′	249 bp
	3’ TATGTGGCTGCAGAGGTGAG 5′
TNF-α	5’ GATCTCAAAGACAACCAACTG 3′	138 bp
	3’ CTGGTATGAAATGGCAAATCG 5′
IL-1β	5’ CCTTGTGCAAGTGTCTGAAGC 3′	147 bp
	3’ CCCAAGTCAAGGGCTTGGAA 5′
IL-10	5’ CATTATGTGGGCACTGGCCT 3′	156 bp
	3’ GTAGATGCCGGGTGGTTCAA 5′
IL-12	5’ CCCATGGATCTTCGGGCAAG 3′	283 bp
	3’ TCACGGACCTGCTCACCTAC 5′